Limited placental transfer and clearance of risankizumab by 6 months following in utero exposure. Balmer C, Korgaard J, Holmboe CH, Neldeborg S, et al. J Crohns Colitis 2026;20:jjag086.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Balmer C, Korgaard J, Holmboe CH, Neldeborg S, et al. Limited placental transfer and clearance of risankizumab by 6 months following in utero exposure. J Crohns Colitis 2026;20:jjag086.
PMID: 42357951